Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial
- Resource Type
- Article
- Source
- The Lancet Haematology; December 2023, Vol. 10 Issue: 12 pe955-e965, 11p
- Subject
- Language
- ISSN
- 23523026